
Humira: An injected biologic for moderate to severe plaque psoriasis. It blocks TNF, one of the main inflammation signals behind psoriasis, and is usually given as a shot under the skin every other week. Sotyktu: A once-daily tablet for moderate to severe plaque psoriasis. It blocks TYK2, an enzyme inside immune cells, and is taken by mouth rather than injected.


Choose for moderate to severe psoriasis or hidradenitis suppurativa — the first approved biologic for HS, now with cheaper biosimilars.
Choose for moderate to severe psoriasis when you want a once-daily pill rather than injections.
Can you take them together?
Sotyktu is not taken with biologics such as Humira, as this raises infection risk. Switch from one to the other instead.
Compare uses by strength of evidence. Evidence level describes confidence in a benefit, not its size.










Binds TNF: Captures an immune messenger that promotes inflammation. Reduces inflammatory signaling: TNF has less ability to activate its receptors. Lets inflamed skin settle: Conditions such as psoriasis can improve over time.
Adalimumab binds TNF-alpha and inhibits its interaction with p55/p75 TNF receptors. This image focuses on skin inflammation; Humira also has other indications.

Inhibits TYK2: Keeps this signaling enzyme in an inactive state. Reduces immune messages: Limits signals from IL-23, IL-12, and type I interferons. Helps psoriasis settle: Inflammation and plaque buildup gradually decrease.
Deucravacitinib allosterically binds the regulatory domain of TYK2. The exact link between biomarker changes and clinical effects is not fully known.
Adults are not dosed by body weight. You start with a larger loading dose to get levels up fast, then settle into an every-other-week rhythm.
Starting dose: 80 mg on day one, as one 80 mg injection or two 40 mg injections at different spots.
One week later: 40 mg.
Usual dose: 40 mg every other week, the same day of the week each time.
If it stops working: Some people move to weekly injections, others switch drugs. The prescriber's call.
Other conditions: Hidradenitis suppurativa uses a heavier loading dose and weekly maintenance, so do not assume a friend's schedule matches yours.
How long: Long term, with no set course length. It continues while it works and is tolerated.
Dosing is as simple as it gets for a systemic drug. No loading dose, no build-up, no weight adjustment.
Starting dose: 6 mg once a day from day one. Full dose from the start.
Going up: No higher approved dose for psoriasis. If it is not working, the conversation is about switching.
Usual dose: 6 mg once a day, long term.
Kidney function: No dose change for most levels of reduced kidney function.
Severe liver disease: Not recommended, so tell your doctor about any liver condition before you start.
Any time of day, but pick a set day of the week and keep to it. Every other week is easy to lose track of, so set a phone reminder on day one.
Take the pen or syringe out of the fridge 15 to 30 minutes before injecting. Cold liquid stings more. Do not warm it in the microwave or hot water.
Inject into the front of the thigh or the belly, at least two inches from the navel. Rotate the spot each time, and avoid skin that is bruised, red, hard, tender or scarred. Never inject through a plaque. A nurse or pharmacist should train you in person for the first dose. Used pens go in a sharps container, never the household bin.
Once a day, at whatever time suits you, with or without food. Pick one time and keep to it, because a daily tablet is easy to lose track of in a way a fortnightly injection is not. Attaching it to something you already do, like brushing your teeth at night, works better than intending to remember.
Swallow the tablet whole with water. Do not crush, split or chew it. If it upsets your stomach, take it with a meal.
Inject as soon as you remember, then return to your original schedule rather than shifting future doses. Never inject two doses to catch up. If you have missed more than one dose, call the prescriber before restarting — long gaps can blunt how well it works.
Take it as soon as you remember on the same day. If you do not remember until the next day, skip it and take that day's tablet as usual. Never take two in one day. Missing the occasional dose will not undo months of progress, but repeatedly missing them is one of the commonest reasons a treatment looks like it has stopped working.
Everyone is screened for tuberculosis before the first dose — a skin test or TB blood test, often with a chest X-ray. TNF blockers can wake a dormant TB infection, so a positive screen is treated first and adalimumab waits until that treatment is under way. Testing is often repeated yearly, or sooner if you live somewhere TB is common.
Hepatitis B and C are checked too, because hepatitis B can reactivate when the immune signal is blocked.
After that there is no fixed blood test schedule like methotrexate's. Many doctors check a blood count and liver tests occasionally. Most monitoring is clinical — how the skin looks, and whether you are getting more infections than usual.
Skin should be checked periodically, because TNF blockers are linked to a small increase in skin cancer. The label also carries a boxed warning about serious infections and about lymphoma and other cancers, based mostly on rare cases in children and young adults. The absolute risk is low, but it is why this prescription gets regular review.
Everyone is screened for tuberculosis before starting, with a skin test or a TB blood test, and a chest X-ray if positive. Dormant TB is treated first. This applies even though it is a tablet rather than an injected biologic.
Hepatitis B and C are usually checked at the same time.
Liver blood tests are often checked before starting and again if there is a reason to. Some people show a rise in creatine kinase, a muscle enzyme, or in triglycerides, so those may be looked at too. There is no rigid schedule like methotrexate's; how often anything is repeated is your doctor's judgment.
The rest is clinical. Report repeated infections, cold sores that keep coming back, mouth ulcers that will not heal, and unexplained muscle pain. Skin should be checked periodically, as on any drug that damps down the immune response.
Approximate windows, not promises.
First few minutesThe injection: A sting for a few seconds. Injection site reactions, if they happen, show up in the first weeks.
Weeks 1 to 4Starting: Itching often eases before the plaques look different, and some people see the scale thin early.
Weeks 1 to 4Starting: Itch usually eases before the plaques look different. Early side effects show now, most often a cold, a cold sore or a mouth ulcer.
Weeks 4 to 12Working: Plaques flatten, scale lifts and redness fades from the middle outward. Most of the visible change happens here. Psoriatic arthritis improves on a similar timeline, and hidradenitis suppurativa settles to fewer painful lumps on its own heavier schedule.
Week 16Judge it here: The point the trials measured. Most people reached at least a 75 percent improvement in skin involvement and severity, and a smaller share cleared almost completely.
Week 16Judge it here: Where the trials measured, and the fair point to decide. More than half reached at least a 75 percent improvement in how much skin was involved and how severe it was; a smaller share were clear or nearly clear.
Months 6 to 12Nails: The slowest, because a nail takes months to grow out. Pitting and lifting improve well after the skin has settled.
Months 6 to 12Nails: Nails change last, because a nail takes months to grow out. Judge the new growth at the base, not the damaged tip.
After the first yearLong term: Most people who respond keep responding.
First doseTaking it: One tablet a day, with or without food.
Weeks 4 to 16Working: Scale lifts and plaques flatten steadily. Scalp psoriasis often improves noticeably here, before the trunk.
Months 3 to 6Palms and soles: Stubborn on every treatment, slower than plaques elsewhere.
Beyond 16 weeksLong term: Responders often keep improving slowly through the first year. Because it is a small molecule, the body does not make antibodies against it, so the gradual loss of effect seen with some injected drugs is not an issue here.
Sorted by what to do about them.
The list price is very high, tens of thousands of dollars a year. Almost nobody pays that. What you pay depends on your insurance, and getting there takes paperwork.
Prior authorization is close to universal. Most plans require you to have tried and failed something cheaper first — phototherapy, methotrexate or another systemic drug — and they want records to prove it.
Biosimilars changed the picture. Several have been sold in the United States since 2023, some at much lower list prices. Which one you get is usually decided by your plan's formulary, not your dermatologist, and plans switch year to year. A switch is a paperwork event, not a medical downgrade, though you may need retraining on a different pen.
Manufacturer copay cards can bring the cost down to very little with commercial insurance. By law they cannot be used with Medicare or Medicaid. For those plans, or with no insurance, manufacturer and foundation assistance programs are the usual route, and their rules change often.
Brand only. There is no generic and will not be for years, so there is no cheaper equivalent. The list price is high, in the same range as the injected biologics over a year, which surprises people who assume a tablet must be cheaper.
Almost nobody pays it. What matters is what your plan does, and approval takes paperwork. Prior authorization is close to universal, and most plans want documented failure of something cheaper first: phototherapy, methotrexate or apremilast.
Manufacturer copay cards can bring the monthly cost down to very little on commercial insurance. By law they cannot be used with Medicare or Medicaid. For those plans, or no insurance, the manufacturer's patient assistance program and independent foundations are the usual routes, and the rules change regularly.
One thing in its favor on cost: no infusion visits, no injection training, no cold chain, so the costs around the drug are lower even when the drug is not.
A large protein grown in living cells rather than a factory chemical. That is why it is injected, and why it lives in the fridge.
A sharp sting for a few seconds. Letting it warm to room temperature first makes a real difference, and citrate-free versions sting less than the original.
Some change by 4 weeks, and about 16 weeks before you judge it fairly. If nothing has happened by then, talk about switching.
Yes, apart from live ones. The flu shot, COVID, pneumonia vaccines and Shingrix are fine and usually recommended. Have live vaccines before you start.
A simple cold is usually not a reason to skip a dose. Anything with a fever, or needing antibiotics, should be checked with the prescriber first.
It must be shown to have no clinically meaningful difference from the original. The pen changes; what is inside does the same job.
It works on TYK2, an enzyme in the same family, but binds a different part of it and is far more selective. Its label does not carry the boxed warning the JAK inhibitors carry. The distinction is real, not marketing.
On average the injected biologics clear skin more completely. This clears skin well for a lot of people, and it is a daily tablet with no fridge and no needles. Which trade is right depends on how severe your psoriasis is and how you feel about needles.
Tuberculosis and hepatitis before you start, and usually liver tests. After that, testing follows your situation, not a fixed schedule — much lighter than methotrexate monitoring.
Herpes simplex outbreaks and mouth ulcers are commonly reported. Tell your doctor if they are frequent; they can usually be managed without stopping.
No direct interaction, unlike methotrexate. Ordinary drinking is generally not a problem, but confirm with your doctor if you have a liver condition.
Losing response over time is less of an issue than with injected antibodies, since the body makes no antibodies against a small molecule. If it does stop working, the option is switching class, since there is no higher dose.